Risk factors for the development of visual disorders in polymyalgia rheumatica with giant-cell temporal arteritis;Risikofaktoren fur die entwicklung von sehstorungen bei polymyalgia rheumatica mit riesenzellarteriitis

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 22, 2000, Pages 681-685

  Bohle, W ^a   Stettin, A ^a   Jipp, P ^a  

^a KATHARINENHOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOPSY; CLINICAL FEATURE; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RHEUMATIC POLYMYALGIA; RISK FACTOR; TEMPORAL ARTERITIS; TEMPORAL ARTERY; VISUAL DISORDER; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; BIOPSY; FEMALE; HUMANS; MALE; POLYMYALGIA RHEUMATICA; RETROSPECTIVE STUDIES; RISK FACTORS; TEMPORAL ARTERITIS; VISION DISORDERS;

EID: 0034595998     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024436     Document Type: Article

References (17)

1. Aiello PD, Trautmann JC, McPhee TJ, Kunselmann AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1983; 55: 550-555
2. Bird HA, Esselinck W, Dixon AS, Mowat AG, Wood PH. Polymyalgia rheumatica - a clinical study with particular reference to arterial disease. J Rheumatol 1979; 1: 190-202
3. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheumat Dis 1993; 19: 941-953
4. De Keyser J, de Klippel N, Ebinger G. Trombocytosis and ischaemic complications in giant cell arteritis. Brit med J 1991; 303: 825
5. Delecoeuillerie G, Joly P, Cohen de Lara A, Paolaggi JB. Polymyalgia rheumatica and temporal arteritis: A retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann rheum Dis 1988; 47: 733-739
6. Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Brit J Rheumatol 1997; 36: 251-254
7. Günther R, Tischler H, Herold M. Polymyalgia rheumatica - Klinische Beobachtungen an 90 Patienten. Z Rheumatol 1985; 44: 218-225
8. Gur H, Rapman E, Ehrenfeld M, Sidi Y. Clinical manifestations of temporal arteritis: A report from Israel. J Rheumatol 1996; 23: 1927-1931
9. Hamrin B. Polymyalgia rheumatica. Acta med scand 1972; 533: 1-131
10. Hunder GG, Bloch DA, Michel BA. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthr Rheumatol 1990; 33: 122-1128
11. Jipp P, Fehring K. Polymyalgia rheumatica und Riesenzellarteriitis. Dtsch med Wschr 1984; 109: 1635-1638
12. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994; 101: 1779-1785
13. Mehler MF, Rabinowich L, Bronx MD. The neuro-ophthalmologic spectrum of temporal arteritis. Amer J Med 1988; 85: 839-844
14. Myklebust G, Gran JZ. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: Clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Brit J Rheumatol 1996; 5: 1161-1168
15. Östberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta med scand 1972; 533: 135-164
16. Schneider HA, Weber AA, Ballen PH. The visual prognosis in temporal arteritis. Ann Ophthalmol 1971; 3: 1215-1230
17. Seyfarth B, Harten P, Löffler H. Die Thrombozytose bei Polymyalgia rheumatica. Dtsch med Wschr 1996; 121: 1255-1260